Job Searching in a Still-Hot Market

Despite an overall slowdown in the economy, pharmaceutical and biotechnology companies are optimistic about the future and are investing heavily in research, particularly in the exploding fields of genomics, proteomics, and nanotechnology. Jobs in academia and government seem to be holding strong as well. Universities are investing in the sciences like never before and in government, the National Institutes of Health is poised to receive a record increase in funding. President George W. Bush's 2

Written byJennifer Fisher Wilson
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

"The employment market in the life sciences is in really good shape overall right now," says Ian King, marketing manager for Biospace.com, a Web-based provider of life sciences-related information and services. "I don't see the need for scientists and researchers diminishing any time soon."

As a way to attract scientists early in their careers, many companies are offering education benefits. In the near future, "it will be a great time for master's level candidates to obtain research jobs and continue their education working toward Ph.D.s while earning an income and also getting significant educational assistance from their employer," explains Del Walker, president of Bio-jobs.com, a biotechnology career website. The trend is still in its infancy, notes Walker, but soon companies will have no choice but to begin hiring candidates with master's degrees for positions that only a few years ago were reserved for Ph.D. candidates.

Such efforts are paying off, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies